Sorbitol China News 202408 (12 issues per year)

August 2024 | 9 pages | ID: SC9C80B1F300EN
Guangzhou CCM Information Science & Technology Co., Ltd. (CCM)

Abstracts

On 8 Aug., Weixinkang Medicine announced that its wholly-owned subsidiary, Baiyi Pharma, had received a notification letter from the
NMPA, approving to proceed with clinical trials for its mannitol sorbitol injection

Contents

Editor's Note
Market Dynamics
Baiyi Pharma receives approval for clinical trials of mannitol sorbitol injection
Tianli Pharma net profit soars in H1 2024
CSPC vitamin C sales sip 5.4% in H1 2024
Shandong Fukuan plans to set up functional sugar industrial park
Qingyuan Mingli prepares for toothpaste and mouthwash production line
Analysis on China sorbitol exports in July 2024
Price Update
China's ex-works prices of sorbitol, Aug. 2024